By Elric Langton | 4 October 2022
I have a financial interest in Poolbeg Pharma & Open Orphan.
Continued expansion of IP portfolio enhancing the protection of Poolbeg's growing pipeline
Poolbeg Pharma (AIM: POLB, OTCQB: POLBF) announced a critically important patent update for its POLB 001. The clinical-stage infectious disease pharmaceutical company has β¦